Candido, R.; Gaiotti, S.; Giudici, F.; Toffoli, B.; De Luca, F.; Velardi, V.; Petrucco, A.; Gottardi, C.; Manca, E.; Buda, I.;
et al. Real-World Retrospective Study into the Effects of Oral Semaglutide (As a Switchover or Add-On Therapy) in Type 2 Diabetes. J. Clin. Med. 2023, 12, 6052.
https://doi.org/10.3390/jcm12186052
AMA Style
Candido R, Gaiotti S, Giudici F, Toffoli B, De Luca F, Velardi V, Petrucco A, Gottardi C, Manca E, Buda I,
et al. Real-World Retrospective Study into the Effects of Oral Semaglutide (As a Switchover or Add-On Therapy) in Type 2 Diabetes. Journal of Clinical Medicine. 2023; 12(18):6052.
https://doi.org/10.3390/jcm12186052
Chicago/Turabian Style
Candido, Riccardo, Sara Gaiotti, Fabiola Giudici, Barbara Toffoli, Federica De Luca, Valerio Velardi, Alessandra Petrucco, Chiara Gottardi, Elena Manca, Iris Buda,
and et al. 2023. "Real-World Retrospective Study into the Effects of Oral Semaglutide (As a Switchover or Add-On Therapy) in Type 2 Diabetes" Journal of Clinical Medicine 12, no. 18: 6052.
https://doi.org/10.3390/jcm12186052
APA Style
Candido, R., Gaiotti, S., Giudici, F., Toffoli, B., De Luca, F., Velardi, V., Petrucco, A., Gottardi, C., Manca, E., Buda, I., Fabris, B., & Bernardi, S.
(2023). Real-World Retrospective Study into the Effects of Oral Semaglutide (As a Switchover or Add-On Therapy) in Type 2 Diabetes. Journal of Clinical Medicine, 12(18), 6052.
https://doi.org/10.3390/jcm12186052
